4,7-Dimethoxy-benzothiazol-2-ylamine, 95.0%, 500mg

Sodium tetrachloroaurate(III) dihydrate, 95.0%, 5g

2-(2-BROMO-ETHYL)-[1,2]OXAZINANE, 95.0%, 5g

3-Ethyl-6,7-dimethyl-quinoxaline-2-carboxylic acid, 95.0%, 1g

(E)-1,2-Di(pyridin-4-yl)ethene, 98%, 25g

4-Bromo-N-(pyridin-3-yl)benzenesulfonamide, 98%, 5g

Benzyl 1H-pyrrole-1-carbodithioate, 97%, 5g

(S)-1-N-Boc-Pipecolinic acid, 98.00%, 25g

Piperidine, min 99%, for synthesis, 1L, glass packaging

2-Benzylpyrazine, 95.0%, 1g

Ethyl 2-(adamantan-1-ylamino)-2-oxoacetate, 98%, 5g

METHYL 4-CHLORO-5-METHOXYPICOLINATE, 95.0%, 1g

2-Amino-4-naphthalen-2-yl-thiophene-3-carboxylic acid methyl ester, 95+%, 1g